Kura Oncology Ownership | Who Owns Kura Oncology?


OverviewForecastRevenueFinancialsChartTranscripts

Kura Oncology Ownership Summary


Kura Oncology is owned by 87.94% institutional investors, 1.59% insiders, and 10.47% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 10.86% of KURA shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.10% of its assets in Kura Oncology shares.

KURA Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockKura Oncology87.94%1.59%10.47%
SectorHealthcare Stocks 42.54%10.83%46.63%
IndustryBiotech Stocks 45.22%10.75%44.04%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de9.52M10.86%$84.21M
Bvf inc/il8.62M9.84%$76.26M
Suvretta capital management8.12M9.27%$71.83M
Blackrock6.97M8.30%$143.43M
Vanguard group5.47M6.24%$48.40M
Armistice capital4.67M5.33%$41.35M
State street3.34M3.82%$29.59M
Prosight management, lp2.76M3.15%$24.41M
Goldman sachs group2.61M2.99%$23.14M
Millennium management2.37M2.72%$20.62M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Alethea capital management1.39M7.90%$12.29M
Prosight management, lp2.76M5.69%$24.41M
Bvf inc/il8.62M3.09%$76.26M
Lion point capital, lp46.00K2.31%$407.10K
Sectoral asset management395.87K2.16%$3.50M
Suvretta capital management8.12M1.84%$71.83M
1492 capital management445.64K1.60%$3.94M
Boxer capital1.00M1.08%$20.59M
Dafna capital management463.37K1.01%$4.10M
Sector gamma as438.42K0.96%$3.88M

Top Buyers

HolderShares% AssetsChange
Goldman sachs group2.61M0.00%1.68M
Millennium management2.37M0.01%1.52M
Bvf inc/il8.62M3.09%863.03K
D. e. shaw1.15M0.01%727.99K
Pale fire capital se607.79K0.59%587.69K

Top Sellers

HolderShares% AssetsChange
Deerfield management company, l.p. (series c)---5.41M
Paradigm biocapital advisors lp---4.33M
Ra capital management---4.00M
Ecor1 capital872.50K0.37%-3.33M
Avoro capital advisors---2.25M

New Positions

HolderShares% AssetsChangeValue
Sector gamma as438.42K0.96%438.42K$3.88M
Connor, clark & lunn investment management364.93K0.01%364.93K$3.23B
Susquehanna portfolio strategies343.89K0.05%343.89K$3.04M
Eversept partners, lp263.63K0.16%263.63K$2.33M
Nan fung trinity (hk)230.88K0.20%230.88K$2.04M

Sold Out

HolderChange
National bank of canada /fi/-1.00
Ifp advisors-9.00
Quantbot technologies lp-14.00
Nelson, van denburg & campbell wealth management group-14.00
Smartleaf asset management-17.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20251977.07%77,024,381-6.25%871.00%112-0.89%5016.28%
Jun 30, 2025183-2.14%82,143,9175.53%931.18%11216.67%43-24.56%
Mar 31, 2025187-1.06%80,458,6251.94%921.12%97-19.83%5762.86%
Dec 31, 2024104-43.48%28,722,448-65.13%330.37%68-17.07%14-75.00%
Sep 30, 20241832.23%82,304,5292.31%941.03%82-2.38%56-9.68%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv2.69M3.10%-59.74K
Vanguard US Total Market Shares ETF2.17M2.68%3.54K
iShares Russell 2000 ETF1.89M2.17%-
SPDR® S&P Biotech ETF1.28M1.48%2.86K
HBM Healthcare Investments AG Ord1.21M1.40%-
Vanguard Institutional Extnd Mkt Idx Tr974.31K1.12%-440.17K
Invesco MSCI World ETF897.58K1.03%897.58K
Fidelity Small Cap Index793.04K0.91%44.84K
BlackRock Advantage Small Cap Core Instl769.61K0.89%125.68K
iShares Russell 2000 Value ETF703.32K0.81%-

Recent Insider Transactions


DateNameRoleActivityValue
Dec 09, 2025Hasnain Faheem-Sell$109.76K
Nov 14, 2025Bair Teresa Brophy Chief Legal OfficerSell$98.40K
Nov 14, 2025Powl Brian T. Chief Commercial OfficerSell$99.33K
Nov 14, 2025Leoni Mollie Chief Medical OfficerSell$173.07K
Nov 14, 2025DOYLE THOMAS JAMES SVP, Finance & AccountingSell$50.73K

Insider Transactions Trends


DateBuySell
2025 Q4-6
2025 Q336
2025 Q2-2
2025 Q1-15
2024 Q4-1

KURA Ownership FAQ


Who Owns Kura Oncology?

Kura Oncology shareholders are primarily institutional investors at 87.94%, followed by 1.59% insiders and 10.47% retail investors. The average institutional ownership in Kura Oncology's industry, Biotech Stocks , is 45.22%, which Kura Oncology exceeds.

Who owns the most shares of Kura Oncology?

Kura Oncology’s largest shareholders are Blackrock funding, inc. /de (9.52M shares, 10.86%), Bvf inc/il (8.62M shares, 9.84%), and Suvretta capital management (8.12M shares, 9.27%). Together, they hold 29.97% of Kura Oncology’s total shares outstanding.

Does Blackrock own Kura Oncology?

Yes, BlackRock owns 8.30% of Kura Oncology, totaling 6.97M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 143.43M$. In the last quarter, BlackRock increased its holdings by 66.44K shares, a 0.96% change.

Who is Kura Oncology’s biggest shareholder by percentage of total assets invested?

Alethea capital management is Kura Oncology’s biggest shareholder by percentage of total assets invested, with 7.90% of its assets in 1.39M Kura Oncology shares, valued at 12.29M$.

Who is the top mutual fund holder of Kura Oncology shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Kura Oncology shares, with 3.10% of its total shares outstanding invested in 2.69M Kura Oncology shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools